Juan Manuel Leyva-Castillo, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dermatitis, Atopic | 15 | 2023 | 644 | 4.440 |
Why?
|
Skin | 16 | 2023 | 4324 | 1.460 |
Why?
|
Interleukins | 5 | 2020 | 788 | 1.310 |
Why?
|
Interleukin-13 | 5 | 2023 | 388 | 1.140 |
Why?
|
Th2 Cells | 6 | 2023 | 1048 | 1.130 |
Why?
|
Keratinocytes | 5 | 2020 | 793 | 1.130 |
Why?
|
Staphylococcal Infections | 4 | 2023 | 1403 | 1.050 |
Why?
|
Ovalbumin | 7 | 2023 | 721 | 1.030 |
Why?
|
Interleukin-4 | 5 | 2023 | 1139 | 1.030 |
Why?
|
Basophils | 3 | 2021 | 388 | 0.970 |
Why?
|
Ant Venoms | 1 | 2023 | 2 | 0.960 |
Why?
|
Mast Cells | 3 | 2020 | 1542 | 0.940 |
Why?
|
Staphylococcal Skin Infections | 2 | 2021 | 73 | 0.910 |
Why?
|
Mice, Inbred BALB C | 11 | 2023 | 6397 | 0.840 |
Why?
|
Lymphocytes | 2 | 2020 | 2612 | 0.800 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2020 | 40 | 0.750 |
Why?
|
Allergens | 7 | 2020 | 1308 | 0.730 |
Why?
|
Hypersensitivity | 2 | 2020 | 1086 | 0.730 |
Why?
|
Cytokines | 6 | 2023 | 7298 | 0.700 |
Why?
|
Food Hypersensitivity | 3 | 2023 | 613 | 0.640 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 973 | 0.530 |
Why?
|
Th1 Cells | 1 | 2020 | 1055 | 0.530 |
Why?
|
Psoriasis | 1 | 2023 | 888 | 0.530 |
Why?
|
Inflammation | 6 | 2023 | 10534 | 0.480 |
Why?
|
Antigens | 4 | 2023 | 1462 | 0.420 |
Why?
|
Staphylococcus aureus | 4 | 2023 | 1449 | 0.340 |
Why?
|
Asthma | 3 | 2020 | 5950 | 0.340 |
Why?
|
Mice | 16 | 2023 | 81002 | 0.310 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3036 | 0.310 |
Why?
|
Immunization | 3 | 2018 | 1255 | 0.300 |
Why?
|
Plasminogen | 1 | 2006 | 152 | 0.280 |
Why?
|
Animals | 23 | 2023 | 168368 | 0.280 |
Why?
|
Pruritus | 3 | 2023 | 352 | 0.270 |
Why?
|
Mice, Knockout | 7 | 2020 | 14558 | 0.260 |
Why?
|
Conjunctivitis | 1 | 2006 | 157 | 0.260 |
Why?
|
Disease Models, Animal | 8 | 2022 | 18003 | 0.260 |
Why?
|
Immunoglobulin E | 3 | 2020 | 1461 | 0.250 |
Why?
|
Interleukin-23 | 2 | 2016 | 190 | 0.250 |
Why?
|
Ticks | 1 | 2023 | 70 | 0.230 |
Why?
|
Receptors, Interleukin-4 | 1 | 2023 | 65 | 0.230 |
Why?
|
Receptor, PAR-1 | 1 | 2023 | 114 | 0.220 |
Why?
|
Ceramides | 1 | 2023 | 199 | 0.210 |
Why?
|
Sequence Deletion | 1 | 2006 | 1528 | 0.210 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2020 | 2986 | 0.210 |
Why?
|
Skin Diseases, Infectious | 1 | 2022 | 74 | 0.200 |
Why?
|
Dendritic Cells | 3 | 2020 | 2728 | 0.200 |
Why?
|
Peptide Hydrolases | 1 | 2023 | 627 | 0.190 |
Why?
|
Eczema | 1 | 2023 | 225 | 0.190 |
Why?
|
Anaphylaxis | 2 | 2019 | 747 | 0.190 |
Why?
|
Dermatitis, Contact | 1 | 2020 | 129 | 0.180 |
Why?
|
Epidermis | 3 | 2022 | 523 | 0.180 |
Why?
|
B-Cell Maturation Antigen | 1 | 2020 | 136 | 0.170 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2020 | 177 | 0.170 |
Why?
|
Interleukin-12 | 1 | 2020 | 578 | 0.160 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2018 | 45 | 0.160 |
Why?
|
T-Lymphocyte Subsets | 3 | 2020 | 1834 | 0.150 |
Why?
|
Interleukin-17 | 1 | 2023 | 894 | 0.150 |
Why?
|
Base Sequence | 2 | 2017 | 12804 | 0.140 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2020 | 578 | 0.140 |
Why?
|
Oral Ulcer | 1 | 2017 | 96 | 0.140 |
Why?
|
Respiratory Hypersensitivity | 1 | 2018 | 274 | 0.140 |
Why?
|
Skin Ulcer | 1 | 2017 | 118 | 0.140 |
Why?
|
Transcription Factor RelA | 1 | 2017 | 276 | 0.140 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2020 | 4374 | 0.130 |
Why?
|
Haploinsufficiency | 1 | 2017 | 327 | 0.130 |
Why?
|
Genes, Dominant | 1 | 2017 | 883 | 0.120 |
Why?
|
Green Fluorescent Proteins | 1 | 2020 | 2092 | 0.120 |
Why?
|
Dermatitis | 1 | 2016 | 195 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1777 | 0.120 |
Why?
|
Cell Polarity | 1 | 2016 | 644 | 0.110 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 560 | 0.110 |
Why?
|
Immunity, Innate | 2 | 2021 | 2950 | 0.100 |
Why?
|
Immunomodulation | 1 | 2016 | 540 | 0.100 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21863 | 0.100 |
Why?
|
Up-Regulation | 1 | 2020 | 4205 | 0.100 |
Why?
|
Calcitriol | 1 | 2012 | 298 | 0.100 |
Why?
|
Gene Expression | 2 | 2020 | 7788 | 0.090 |
Why?
|
Humans | 19 | 2023 | 739398 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2022 | 3435 | 0.090 |
Why?
|
Dermatologic Agents | 1 | 2012 | 274 | 0.080 |
Why?
|
Female | 12 | 2020 | 378853 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4522 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4663 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2020 | 19220 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2019 | 10455 | 0.070 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2006 | 380 | 0.070 |
Why?
|
Consanguinity | 1 | 2006 | 456 | 0.060 |
Why?
|
Mexico | 1 | 2006 | 683 | 0.060 |
Why?
|
Mutation | 1 | 2006 | 29658 | 0.050 |
Why?
|
Immune Tolerance | 2 | 2020 | 2256 | 0.050 |
Why?
|
Child, Preschool | 2 | 2019 | 40802 | 0.050 |
Why?
|
Oxazolone | 1 | 2020 | 60 | 0.050 |
Why?
|
Exons | 1 | 2006 | 2430 | 0.050 |
Why?
|
Cellulitis | 1 | 2022 | 206 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15511 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2018 | 8 | 0.040 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2018 | 13 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10142 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23355 | 0.040 |
Why?
|
Endopeptidases | 1 | 2022 | 771 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4182 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2021 | 1581 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 6174 | 0.040 |
Why?
|
Dextran Sulfate | 1 | 2017 | 236 | 0.040 |
Why?
|
Polysaccharides | 1 | 2023 | 1050 | 0.040 |
Why?
|
Receptor, PAR-2 | 1 | 2016 | 31 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2020 | 1858 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9734 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2016 | 708 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1778 | 0.030 |
Why?
|
Male | 4 | 2020 | 349022 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2020 | 3193 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2020 | 6370 | 0.030 |
Why?
|
Child | 1 | 2019 | 77033 | 0.020 |
Why?
|
Adolescent | 1 | 2019 | 85405 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4640 | 0.020 |
Why?
|
Ligands | 1 | 2016 | 3311 | 0.020 |
Why?
|
Colitis | 1 | 2017 | 1146 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1675 | 0.020 |
Why?
|
NF-kappa B | 1 | 2017 | 2502 | 0.020 |
Why?
|
Glycoproteins | 1 | 2016 | 2259 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2016 | 2049 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4137 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4791 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5959 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4400 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3454 | 0.020 |
Why?
|
Cell Movement | 1 | 2016 | 5221 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7136 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9133 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9387 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 13002 | 0.010 |
Why?
|
Adult | 1 | 2016 | 213394 | 0.000 |
Why?
|